Tudlasan, Isidra M.

HRN: 27-56-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
LEVOFLOXACIN 500MG (TAB)
08/06/2025
08/13/2025
PO
500
Bid
Cap Hr
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: